Prolific Machines
Drug Discovery · Synthetic Biology
9open roles
$170kmedian advertised pay
$55Mlatest round · Series B · Jun 2024 · 2 yr ago
1backers · SOSV
Overview
Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Funding and backers
Total raised
$55M
1 round on record
Latest round
$55M
Series B · Jun 2024 · 2 yr ago
Team
54
US Form 5500 (plan participants) · Dec 2025 · +13% in a year
Hiring now
9
+6 posted in 30 days
Backers
1
SOSV
The money's age
Long since its last round
29 months since the last round · and hiring
Momentum
42/100
hiring for its size, in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team of 54 was 48 · US Form 5500 (plan participants)
May 14, 2025
New executive Prolific Machines Appoints Former Catalent Chief Scientific Officer to Board of Directors · businesswire.com
Feb 12, 2025
New executive Prolific Machines Announces the Appointment of Former Forge Biologics Executive, Christina Perry, as CFO Setting the Stage for Optogenetics Leader's… · businesswire.com
Jun 6, 2024
Raised a round Series B $55M · FoodNavigator.com
2020
Founded
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Jun 2024 | $55M | — | FoodNavigator.com |
Registers and programsofficial lists and records that name the company
| Legal entity | Prolific Machines Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Max HuismanExecutive Officer, DirectorSEC Form D
Deniz KentExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
StrainX Bioworks is a next-generation synthetic biology company engineering microbial strains and precision fermentation to produce…
Xylo is pioneering next-generation therapeutics designed to rewire neural circuits and restore brain function. Discover our innovative…
Immunoassays for any Protein, any Specimen and any Species. SIGNATOPE offers next generation quantitative assays for your protein biomarker…
Biology meets artificial and human intelligence for next-generation therapeutics. Onava is built differently. Our platform compounds in…
GlycoEra is a biotechnology company developing a novel protein expression technology for biologic drug candidates. Its scientists work on…
Constructive Bio designs and manufactures new-to-nature chemistries for next-generation therapies and materials.
Jobs
$73k – $118k per year · In office · Full-Time · Bachelor's Degree · Emeryville
PCR
Flow Cytometry
Cell Culture
Bioreactors
Apply
$125k – $185k per year · In office · Full-Time · 7+ years exp · PhD · Emeryville
Flow Cytometry
Molecular Cloning
Apply
$150k – $180k per year · In office · Full-Time · 5+ years exp · Master's Degree · Emeryville
Mass Spectrometry
HPLC
Chromatography
ICH Guidelines
Apply
$70k – $100k per year · In office · Full-Time · Bachelor's Degree · Emeryville
HPLC
Chromatography
Apply
$120k – $170k per year · In office · Full-Time · 5+ years exp · Bachelor's Degree · Emeryville
FMEA
Life Sciences
Cell Culture
Bioreactors
GMP
GLP
Apply
$85k – $115k per year · In office · Full-Time · 2+ years exp · Bachelor's Degree · Emeryville
PCR
Cell Culture
Molecular Cloning
Design of Experiments
Apply
$220k – $270k per year · In office · Full-Time · 10+ years exp · PhD · Emeryville
Bioreactors
GMP
MedTech
Design Controls
Verification & Validation
Apply
$120k – $140k per year · In office · Full-Time · 1+ year exp · PhD · Emeryville
Cell Culture
Mass Spectrometry
HPLC
GLP
Apply
$115k – $175k per year · In office · Full-Time · 4+ years exp · PhD · Emeryville
Python
Cell Culture
Bioreactors
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$170k
Typical range
$100k – $270k
Open positions
9
7
Jobs
Junior
28.6%
Middle
14.3%
Senior
42.9%
Architect
14.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 2 | $128k | $115k – $140k |
| Middle | 1 | $175k | $175k |
| Senior | 3 | $180k | $170k – $185k |
| Architect | 1 | $270k | $270k |
Highest paying role
Head Of/Director, Hardware Engineering
$270k
Normalized to USD per year
All salaries at Prolific Machines
By role, level and city, against the market · 9 jobs with pay
Visa sponsorship
1
H-1B filings in 12 months
$113k
Median offered salary
9
Open roles in United States
Who they sponsor
Microbiologists
1
In the register as Prolific Machines, Inc., Emeryville, CA
Other sponsors in the same field
Serif Biomedicines 
Antheia 
Codexis 
Arbor Biotechnologies
See 9 open roles Alert me
US Department of Labor · latest filing Feb 10, 2026 · Visa details by country
Growth
Hiring Momentum
56/100
Growing
Open positions
9
4 opened / 2 closed in 30 days
Median time-to-fill
54 days
faster than 25% of the market
ATS activity
Every ~6 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
33% ▲
Biotech
25%
Leadership
17% ▼
DevOps
8% ▲
Hardware
8% ▲
Semiconductors
8% ▼
Actively hiring for Science & Research (+3 in 30 days)
Activity Timeline
Added ICH Guidelines to stack
Nov 2026
Added Chromatography to stack
Nov 2026
Added FMEA to stack
Oct 2026
Added Google Workspace to stack
Oct 2026
Added TCP/IP to stack
Sep 2026
Added Linux to stack
Sep 2026
Added Microsoft Office to stack
Sep 2026
Financials
Total raised
$55M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2024 | $55M | Details |
People
Max Huisman
Executive Officer, Director
Deniz Kent
Executive Officer, Director
Arvind Gupta
Director
Campbell Grieve
Director
Cooper Rinzler
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at Prolific Machines over the last 12 months, by layer, with the share of postings for each.
Technologies in use
31
Postings analysed
10
Stack modernity
66/100
Languages
Python20%
Go10%
Rust10%
SQL10%
Databases
MySQL10%
PostgreSQL10%
Cloud & platforms
Linux10%
Sign in to see how your skills match this stack
Sign In
Full Prolific Machines tech stack
31 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
780 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Awards CPHI Milan
CPHI Celebration includes our annual pharma Awards ceremony recognising the teams, individuals and companies whose products and solutions enable purposeful change within our industry.
Read more
Report
Light-controlled expression: the future of biomanufacturing introduction calameo.com 22 Jun 2026 Read more
Read more
Report
Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform Fierce Pharma 05 May 2026
Read more
Report
Figuring Out the New Economics of Niche
As smaller batch products become more prominent within drug development, companies are being required to adopt more agile, modular approaches to ensure commercial viability is achievable.
Read more
Report
Report
Prolific Machines Announces the Appointment of Former Forge Biologics Executive, Christina Perry, as CFO Setting the Stage for Optogenetics Leader's Biopharmaceutical ...
Read more
Report
Prolific Machines Receives Grant to Develop a Platform to Produce Affordable Monoclonal Antibodies to Prevent Infectious Disease in Low- and Middle-Income Countries
Read more
Report
Prolific Machines raises $55m in Series B1 funding to shine light on optogenetics' potential in biotech
Biomanufacturing technology provider Prolific Machines raised $55 million in Series B1 funding, which will go to support the commercialization of its light-based biotech platform, company Co-founder and CEO Deniz Kent told FoodNavigator-USA.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Emeryville
Emeryville
United States
HQ
Start a Conversation
10 open roles 12 posted in 90 days 50% engineering 50-200 est. staff $161k Avg Salary
hires for Science & Research, Biotech, DevOps
Location 6400 Hollis St. Emeryville, California, USA